News & features
![Digital pathology helps decode tumor microenvironments for precision immunotherapy. GigaPath is a novel vision transformer that can scale to gigapixel whole-slide images by adapting dilated attention for digital pathology. In joint work with Providence and UW, we’re sharing Prov-GigaPath, the first whole-slide pathology foundation model pretrained on large-scale real-world data, for advancing clinical research and discovery.](https://www.microsoft.com/en-us/research/uploads/prodnew/2024/05/1-hero-480x280.png)
GigaPath: Whole-Slide Foundation Model for Digital Pathology
| Hoifung Poon and Naoto Usuyama
Digital pathology helps decode tumor microenvironments for precision immunotherapy. In joint work with Providence and UW, we’re sharing Prov-GigaPath, the first whole-slide pathology foundation model, for advancing clinical research.
![The KDD2023 logo in white with the dates August 6-10 and the city Long Beach, CA on a green and blue gradient background](https://www.microsoft.com/en-us/research/uploads/prod/2023/08/KDD23-MSRNewsletterThumb-290x163-1.png)
Microsoft at KDD 2023: Advancing health at the speed of AI
| Hoifung Poon
This content was given as a keynote at the Workshop of Applied Data Science for Healthcare and covered during a tutorial at the 29th ACM SIGKDD Conference on Knowledge Discovery and Data Mining (opens in new tab), a premier forum…
![a screenshot of a cell phone](https://www.microsoft.com/en-us/research/uploads/prod/2020/08/1400x788_BioMed_still_noLogo-5f496ecc6934d-480x280.png)
Domain-specific language model pretraining for biomedical natural language processing
| Hoifung Poon and Jianfeng Gao
COVID-19 highlights a perennial problem facing scientists around the globe: how do we stay up to date with the cutting edge of scientific knowledge? In just a few months since the pandemic emerged, tens of thousands of research papers have…
In the news | The AI Blog
Cancer researchers embrace AI to accelerate development of precision medicine
Biomedical researchers are embracing artificial intelligence to accelerate the implementation of cancer treatments that target patients’ specific genomic profiles, a type of precision medicine that in some cases is more effective than traditional chemotherapy and has fewer side effects.